Klotho Neurosciences, Inc.
KLTO
$0.48
$0.049.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -168.21% | -714.37% | -538.96% | -769.30% | -514.62% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 195.57% | 1,871.74% | 1,261.33% | -- | 2,039.10% |
| Change in Net Operating Assets | -347.07% | -1,358.90% | -210.49% | -42.21% | -156.11% |
| Cash from Operations | -152.26% | -398.63% | -1,358.73% | -559.34% | -527.68% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 100.00% | 100.00% | -616.74% | 81.52% |
| Cash from Investing | 100.00% | 100.00% | 100.00% | -616.74% | 81.52% |
| Total Debt Issued | 174.34% | 280.74% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,227.09% | 4,225.16% | -100.00% | 75.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -105.73% | -104.69% | -- | 163.56% | -- |
| Cash from Financing | 465.18% | 557.76% | 1,722.47% | 794.54% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14,853.07% | 842.43% | 538.73% | 183.42% | 110.23% |